Dianthus Therapeutics, Inc. (DNTH) ownership: Top institutional holder: FMR LLC ($651.86M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| FMR LLC | 7767686.00 | $651.86M | 2026-03-31 |
| BlackRock, Inc. | 3175703.00 | $266.50M | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 2611733.00 | $219.18M | 2026-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 2595783.00 | $217.84M | 2026-03-31 |
| Fairmount Funds Management LLC | 2537191.00 | $212.92M | 2026-03-31 |
| Avidity Partners Management LP | 2104184.00 | $176.58M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2031249.00 | $170.46M | 2026-03-31 |
| Octagon Capital Advisors LP | 1946667.00 | $163.36M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 |
Back to DNTH overview · DNTH earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.